Alamar Biosciences (ALMR) vs Bruker (BRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bruker is the larger company by market cap ($8.80 billion vs $1.83 billion), about 4.8 times the size. Bruker pays a dividend yielding 0.35%, while Alamar Biosciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | BRKR |
|---|---|---|
| Share price | $26.38 | $57.74 |
| Market cap | $1.83B | $8.80B |
| 1-day change | -5.02% | -3.32% |
| YTD return | — | +26.77% |
| 1-year return | — | +72.80% |
| 5-year return | — | -22.67% |
| Forward P/E | — | 23.93 |
| EPS (TTM) | $-1.20 | $-0.70 |
| Dividend yield | 0.00% | 0.35% |
| Annual dividend | $0.00 | $0.20 |
| Revenue (latest FY) | — | $3.44B |
| Revenue growth (YoY) | — | +2.08% |
| Net income (latest FY) | — | $-8.60M |
| Gross margin | — | 45.91% |
| Operating margin | — | 1.98% |
| Net margin | — | -0.25% |
| 52-week high | $39.61 | $66.98 |
| 52-week low | $18.85 | $32.37 |
| Distance from 52-week high | -33.41% | -13.80% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +34.22% | +9.55% |
| Average volume | 399.23K | 2.23M |
| Shares outstanding | 69.39M | 152.36M |
| Employees | 286 | 11,085 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bruker is about 4.8 times larger than Alamar Biosciences by market value ($8.80B vs $1.83B).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Bruker
BRKR stock →Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees
ALMR vs BRKR FAQ
Which is bigger, Alamar Biosciences or Bruker?
Bruker (BRKR) is larger, with a market capitalization of $8.80B compared with $1.83B for Alamar Biosciences (ALMR).
Which pays a higher dividend, Alamar Biosciences or Bruker?
Bruker pays a dividend yielding 0.35%, while Alamar Biosciences does not currently pay a regular dividend.
Are Alamar Biosciences and Bruker in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.